Forecast & Rating3 analysts currently cover Dogwood Therapeutics, of which 2 give a positive rating. The average price target is $14.00, about 621.6% upside from the current price of $1.94. Coverage is limited, so the data is for reference only. Data as of Sep 2, 2026; this does not constitute investment advice.
Sep 2, 2026Price forecast
$14.00621.65%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 7, 2026
Forecast met16.2%
Stock price$1.94
Avg. target$14.0
High target$15
Low target$12
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.